Thrombolysis Plus Aortic Counterpulsation: Improved Survival in Patients Who Present to Community Hospitals With Cardiogenic Shock
Authors:
- Mark A RasakMRMark A Rasak
- Eric R BatesEBEric R Bates
- E.MAgnus OhmanEOE.MAgnus Ohman
- Robert J StomelRSRobert J Stomel
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experienceJACC, 1995
- Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patientsThe Lancet, 1994
- The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Marked systemic hypotension depresses coronary thrombolysis induced by intracoronary administration of recombinant tissue-type plasminogen activatorJACC, 1992
- Cardiogenic Shock after Acute Myocardial InfarctionNew England Journal of Medicine, 1991
- Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shockJACC, 1991
- In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparinThe Lancet, 1990
- Results of a randomized prospective trial of intraaortic balloon counterpulsation and intravenous nitroglycerin in patients with acute myocardial infarctionJACC, 1985
- Randomized controlled trial of intraaortic balloon counterpulsation in early myocardial infarction with acute heart failureThe American Journal of Cardiology, 1981